Haleon (HLN) Change in Receivables (2022 - 2023)
Haleon (HLN) posted Change in Receivables of -$197.3 million for Q4 2023, down 82.88% on a QoQ basis from -$107.9 million in Q4 2022, and down 82.88% year-over-year from -$1.2 billion in Q4 2022.
Haleon (HLN) Change in Receivables (2022 - 2023) Analysis & Trends
Haleon's Change in Receivables history runs 2 years deep, the most recent figure standing at -$197.3 million for Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -38.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -197.34 Mn |
| Dec 31, 2023 | -197.34 Mn |
| Dec 31, 2022 | -107.91 Mn |
| Dec 31, 2022 | -107.91 Mn |